Revelation Biosciences (REVB) - Earnings growth in current year
Revelation Biosciences is developing immunotherapy where formula approvals will ensure massive margins through contract manufacturing. The current YoY EPS growth clearly demonstrates the dynamics of this process, and this metric stands at 58.50. The company is implementing innate immunity activation methods for preventive body protection. Currently, the business relies on institutional capital, as the development stage does not yet generate revenue.
Financial and market metric breakdowns for Revelation Biosciences Corp (REVB)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Revelation Biosciences|REVB - Long-Term Debt to Capital|Current Liabilities to Capital Revelation Bio|REVB - Company Total Debt|Debt to Book Capitalization Ratio Revelation Biosciences|REVB - Company Long-Term Debts|Short-Term Debt Revelation Biosciences|Quick Liquidity revbiosciences.com
- earnings and market ratios statistics:
REVB - Net Profit|Projected Future Earnings Revelation Biosciences|REVB - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Revelation Biosciences|REVB - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Revelation Biosciences, Inc.|REVB - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Revelation Biosciences|REVB - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months revbiosciences.com|REVB - Net earnings per share growth this year|Expected earnings per share trend next year Revelation Biosciences
- sales volume and revenue information:
Summary company analysis:Revelation Bio, REVB
The success of Revelation Biosciences (REVB) depends on the effectiveness of R&D in immune stimulation and the results of clinical trials. This annual percentage growth in net income per share captures EPS dynamics relative to the previous year, reflecting the business's ability to generate real income. The stability of this indicator confirms the issuer's financial resilience, minimizing the risks of price volatility during a shift in market trends.
Direct competitors
Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth in current year|Agenus, Inc (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|ZURA (Zura Bio Limited) - Earnings per share increase in current year|Earnings per share growth in current year aTyr Pharma ATYR|ADAG - Net earnings per share growth this year|IMA - Earnings per share growth in current year|Shattuck Labs - Net earnings per one share growth for the current year|EQ: Earnings growth in current year|Earnings per share trend in current year CNTB (Connect Biopharma Holdings)|Net earnings per share growth this year IMUX|ATRA (atarabio.com) - Net earnings per one share growth for the current year|Earnings growth in current year IFRX|Earnings growth in current year X4 Pharma (XFOR)|Adicet Bio Inc. - Net earnings per share growth this year|Earnings growth in current year celularity.com CELU|INMB: Net earnings per share growth this year|BRNS: Earnings per share growth in current year|KZR: Earnings growth in current year|SAB Biotherapeutics Inc - Earnings per share increase in current year|AKTX (Akari Therapeutics, Plc) - Earnings growth in current year|ENLV: Earnings per share increase in current year|Earnings per share growth in current year Q32 Bio (QTTB)|Net earnings per share growth this year GeoVax Labs GOVX|Earnings growth in current year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Earnings per share growth rate in current year|CARM: Net earnings per share growth this year|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth this year|BOLT: Earnings growth in current year|Net earnings per share growth this year HCW Biologics Inc.|Earnings per share growth in current year aptevotherapeutics.com|AIM: Earnings per share increase in current year|Earnings per share growth in current year aditxt.com (ADTX)|GRI - Earnings per share growth rate in current year|Earnings growth in current year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Earnings per share growth rate in current year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year
